Trinity Capital Inc. (TRIN) Earnings

Trinity Capital Inc. is expected to report next earnings on August 5, 2026 (in NaN days), with a consensus EPS estimate of $0.52. TRIN has beaten EPS estimates in 7 of its last 12 reported quarters (average surprise +1.5% over the last four).

Next earnings
Aug 5, 2026in NaN days
EPS est $0.52 · Revenue est $91M
Track record
Beat EPS in 7 of 12 quarters
Avg surprise +1.5% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 6, 2026$0.52$0.53+1.9%$90M+5.0%
Feb 25, 2026$0.51$0.52+2.0%$78M-6.3%
Nov 5, 2025$0.52$0.52+0.0%$66M-17.0%
Aug 6, 2025$0.52$0.53+1.9%$62M-10.3%
May 1, 2024$0.55$0.52-5.5%$28M-46.6%
Mar 6, 2024$0.55$0.54-1.8%$49M+4.7%
Nov 1, 2023$0.55$0.55+0.0%$45M-2.2%
Aug 2, 2023$0.53$0.61+15.1%$32M-15.4%
May 4, 2023$0.57$0.52-8.8%$34M-18.0%
Mar 2, 2023$0.49$0.57+16.3%$8M-79.0%
Nov 3, 2022$0.52$0.53+1.9%$37M+5.2%
Aug 4, 2022$0.45$0.48+6.7%$2M-92.6%

Source: company filings + earnings calendar. For informational purposes only — not investment advice.

Earnings call summary

Q1 FY2026 · May 6, 2026

AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.

Management highlights

- Trinity Capital has a diversified lending platform of five complementary verticals, an expanding managed funds platform, and an internally managed structure. - Net asset value grew 7% QoQ and 40% YoY to $1.2 billion; platform AUM up 36% YoY to over $2.9 billion. - Originations robust with $306 million fundings and $396 million commitments. - Strong credit with non-accruals at 1% of portfolio. - Paying $0.17 monthly dividend through end of Q2, scheduled Q3 dividend announcement. - TRIN's year-to-date total return leads BDC space, cumulative return since IPO 119% vs S&P 500's 86%. - ROE 15.8% in Q1. - Managed funds platform AUM $400 million, income contributed 4 cents to NII. - Investment pipeline robust with $1.2 billion unfunded commitments and $300 million term sheets accepted. - 94% unfunded commitments subject to diligence and investment committee approval. - Diversified lending verticals with no syndicated deals, low overlap with other BDCs. - Joint venture with Capital Southwest for lower middle market co-investment. - Enterprise SaaS 10% of portfolio, AI exposure on infrastructure side via equipment financing. - High-performance culture rooted in humility, trust, etc., attracting top talent.

Guidance

- Paying $0.17 monthly dividend through end of Q2, scheduled to announce Q3 dividend in June subject to board approval. - 197 warrant positions and 127 portfolio companies with upside potential. - Initial close of $45.3 million in equity commitments to SBIC fund, expect to deploy from fund this quarter. - Joint venture with Capital Southwest for lower middle market expansion provides new investment capacity.

Segment performance

Trinity Capital's net asset value grew 7% quarter-over-quarter and 40% year-over-year to a record $1.2 billion. Platform AUM increased to more than $2.9 billion, up 36% year-over-year. Originations engine achieved $306 million of fundings and $396 million of commitments. Non-accruals were 1% of the portfolio at fair value. Managed funds AUM sat at $400 million across four vehicles. Income generated from the managed funds platform contributed 4 cents to the 53 cents per share net investment income in Q1. Fundings in Q1 across five verticals were: 41% to life sciences, 22% to equipment financing, 13% to sponsor finance, 13% to tech lending, and 11% to asset-backed lending.

Risks & headwinds

- Certain statements may be forward-looking, review SEC filings for risks. - Non-accruals at 1% of portfolio. - Market valuation dynamics and mark-to-market adjustments causing unrealized depreciation. - Prepayment variability in portfolio. - Sector-specific pressures (e.g., software) affecting some verticals.

Analyst Q&A

  • Q: How are you focusing on AI?

    A: Not making many venture debt investments in AI, mostly lower middle market, small public companies, private equity-backed deals, and equipment financing for AI infrastructure.

  • Q: Why was life sciences the leader in origination this quarter?

    A: Deal flow can be idiosyncratic; life sciences team had great quarter due to early quarter activity at J.P. Morgan, diversified platform means outsized performance from verticals can vary.

  • Q: Expense requirements for new fund vehicles?

    A: Using same resources, limited back office/operations support for new vehicles, built platform to scale long-term.

  • Q: Pipeline across verticals and spreads?

    A: Manufacturing, infrastructure, AI booming, some pressure on tech lending/life sciences, but lower middle market and equipment financing robust, not a race to the bottom in pricing.

  • Q: Are new vehicles co-investing same portfolio companies as TRIN?

    A: SBIC fund co-invests eligible deals originated by TRIN; Capital Southwest joint venture has largely transactions originated by Capital Southwest with 50-50 governance.

  • Q: Higher leverage ratios with SBIC sub?

    A: No, utilizing third party capital for SBIC fund, strategy to deleverage TRIN BDC over time.

  • Q: Equity investments in lower middle market?

    A: Focused on being a lender, returns primarily rate and fee income, strategy not changing.